Can sPD-1 and sPD-L1 Plasma Concentrations Predict Treatment Response among Patients with Extraparenchymal Neurocysticercosis?

Extraparenchymal neurocysticercosis (EP-NC) is a chronic, potentially life-threatening disease that responds poorly to initial anthelmintic drug therapy. A depressed specific reactivity of peripheral lymphocytes and an increased level of specific Tregs accompanies EP-NC. The immune checkpoint pathwa...

Descripción completa

Detalles Bibliográficos
Autores principales: Toledo, Andrea, Fragoso, Gladis, Carrillo-Mezo, Roger, Romo, Matthew L., Sciutto, Edda, Fleury, Agnès
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535301/
https://www.ncbi.nlm.nih.gov/pubmed/37764924
http://dx.doi.org/10.3390/pathogens12091116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535301/
https://www.ncbi.nlm.nih.gov/pubmed/37764924
http://dx.doi.org/10.3390/pathogens12091116

Ejemplares similares